Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page history.SummaryDifference0.1%

- Check7 days agoChange DetectedNew revision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new history entry on 2026-02-18 updates the Study Status. The 2026-01-12 version was removed from the history.SummaryDifference0.3%

- Check36 days agoChange DetectedAdded a new revision entry (v3.4.2) to the study record history. The notice about government funding status and the older revision entry (v3.4.1) were removed.SummaryDifference0.7%

- Check43 days agoChange DetectedAdded a government funding lapse notice at the top of the page. Updated the site version from v3.4.0 to v3.4.1, removing the previous version reference.SummaryDifference0.7%

- Check50 days agoChange DetectedUI changes add a glossary toggle and color-coded highlights for additions (green) and deletions (red). The page shows a new revision label (v3.4.0) replacing the previous version (v3.3.4).SummaryDifference0.8%

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.